Skip to content

Clinical trials

Phase 2 Major Depressive Disorder trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20091
20101
20112
20122
20131
20151
20171
20181
20202
20212
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Janssen Research & Development, LLC3
Boehringer Ingelheim2
Charite University, Berlin, Germany2
Hoffmann-La Roche2
Seaport Therapeutics2
Affectis Pharmaceuticals AG1
Central Institute of Mental Health, Mannheim1
GH Research Ireland Limited1
Ludwig-Maximilians - University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder26
Depressive Disorder5
Depressive Disorder, Treatment-Resistant4
Mood Disorders3
Anxiety Disorders2
Mental Disorders2
Inflammation1
Obesity1
Psychomotor Disorders1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.